The Race to Develop the Pfizer-BioNTech COVID-19 Vaccine: …
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9482796/
WEBSep 18, 2022 · The two pediatric formulations are based on the second-generation formulation using the Tris/sucrose buffer and require dilution with sterile 0.9% sodium … DOI: 10.1016/j.xphs.2022.09.014 Published: 2023/03 Publication: J Pharm Sci. 2023 Mar; 112(3): 640-647.
DOI: 10.1016/j.xphs.2022.09.014
Published: 2023/03
Publication: J Pharm Sci. 2023 Mar; 112(3): 640-647.
DA: 79 PA: 37 MOZ Rank: 36